The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Celgene Corp

Nasdaq: CELG
Last

(U.S.) $112.61

Today's change0.00 0.00%
Updated November 26 4:15 PM EST. Delayed by at least 15 minutes.
 

Celgene Corp

Nasdaq: CELG
Last

(U.S.) $112.61

Today's change0.00 0.00%
Updated November 26 4:15 PM EST. Delayed by at least 15 minutes.

Celgene Corp closed at (U.S.)$112.61.

Over the last five days, shares have gained 5.26% and 33.29% year to date. Shares have outperformed the S&P 500 by 23.11% during the last year.

Key company metrics

  • Open(U.S.) $111.46
  • Previous close(U.S.) $112.61
  • High(U.S.) $112.82
  • Low(U.S.) $109.20
  • Bid / Ask(U.S.) $112.05 / (U.S.) $113.00
  • YTD % change+33.29%
  • Volume3,269,747
  • Average volume (10-day)3,978,244
  • Average volume (1-month)4,505,965
  • Average volume (3-month)4,873,065
  • 52-week range(U.S.) $66.85 to (U.S.) $112.82
  • Beta1.09
  • Trailing P/E58.94×
  • P/E 1 year forward30.50×
  • Forward PEG1.18×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.91
Updated November 26 4:15 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+21.80%

Based on its net profit margin of 21.80%, Celgene Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.77%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue1,9821,8731,7301,756
Total other revenue--------
Total revenue1,9821,8731,7301,756
Gross profit1,8851,7741,6441,663
Total cost of revenue98998693
Total operating expense1,3381,1161,3681,430
Selling / general / administrative498492494449
Research & development675457714731
Depreciation / amortization64656666
Interest expense (income), net operating--------
Unusual expense (income)43992
Other operating expenses, total--------
Operating income645757362326
Interest income (expense), net non-operating-64-52-40-40
Gain (loss) on sale of assets--------
Other--------
Income before tax578707332217
Income after tax509598280214
Income tax, total69109533
Net income509598280214
Total adjustments to net income--------
Net income before extra. items509598280214
Minority interest------0
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items509598280214
Inc. avail. to common incl. extra. items509598280214
Diluted net income509598280214
Dilution adjustment--------
Diluted weighted average shares833831845859
Diluted EPS excluding extraordinary itemsvalue per share0.610.720.330.25
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.610.720.340.35